A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Mitral valve regurgitation (leakage of the mitral valve of the heart) is frequent and
currently there is no specific medical therapy. Mitral regurgitation is a slowly progressive
disease that frequently requires surgical treatment. This randomized clinical trial will use
Metoprolol, a common beta-blocker medication, to determine if medical treatment impacts
mitral valve disease progression.